High Relaxivity Magnetic Resonance Imaging Contrast Agents Part 1
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 45 (10), 600-612
- https://doi.org/10.1097/rli.0b013e3181ee5a9e
Abstract
Rationale and Objectives: The donor atoms that bind to gadolinium in contrast agents influence inner-sphere water exchange and electronic relaxation, both of which determine observed relaxivity. The effect of these molecular parameters on relaxivity is greatest when the contrast agent is protein bound. We sought to determine an optimal donor atom set to yield high relaxivity compounds. Methods: A total of 38 gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N′,N′′,N′′′-tetraacetato derivatives were prepared and relaxivity was determined in the presence and absence of human serum albumin as a function of temperature and magnetic field. Each compound had a common albumin-binding group and differed only by substitution of different donor groups at one of the macrocycle nitrogens. Oxygen-17 isotope relaxometry at 7.05 T was performed to estimate water exchange rates. Results: Changing a single donor atom resulted in changes in water exchange rates ranging across 3 orders of magnitude. Donor groups increased water exchange rate in the order: phosphonate ∼ phenolate > α-substituted acetate > acetate > hydroxamate ∼ sulfonamide > amide ∼ pyridyl ∼ imidazole. Relaxivites at 0.47 and 1.4 T, 37°C, ranged from 12.3 to 55.6 mM−1s−1 and from 8.3 to 32.6 mM−1s−1 respectively. Optimal relaxivities were observed when the donor group was an α-substituted acetate. Electronic relaxation was slowest for the acetate derivatives as well. Conclusions: Water exchange dynamics and relaxivity can be predictably tuned by choice of donor atoms.Keywords
This publication has 59 references indexed in Scilit:
- In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic AneurysmsInvestigative Radiology, 2010
- Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the RatInvestigative Radiology, 2010
- Bioresponsive, Cell-Penetrating, and Multimeric MR Contrast AgentsAccounts of Chemical Research, 2009
- Pushing the Sensitivity Envelope of Lanthanide-Based Magnetic Resonance Imaging (MRI) Contrast Agents for Molecular Imaging ApplicationsAccounts of Chemical Research, 2009
- Gd−Hydroxypyridinone (HOPO)-Based High-Relaxivity Magnetic Resonance Imaging (MRI) Contrast AgentsAccounts of Chemical Research, 2009
- High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast AgentInvestigative Radiology, 2008
- Gadolinium and nephrogenic systemic fibrosisKidney International, 2007
- Strategies for increasing the sensitivity of gadolinium based MRI contrast agentsChemical Society Reviews, 2006
- Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agentsContrast Media & Molecular Imaging, 2006
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999